Endocrine and Metabolic Characteristics in Polycystic Ovary Syndrome

The document discussed the endocrine and metabolic characteristics of polycystic ovary syndrome (PCOS), a condition often causing hirsutism in 5-25% of women. PCOS was described as a multiorgan disease affecting various endocrine organs and was linked to abdominal obesity, insulin resistance, and increased inflammation, contributing to a vicious cycle of symptoms. The study highlighted the need for screening PCOS patients for metabolic syndrome elements and suggested that prolactin and HbA1c levels could indicate cardiovascular risk. Treatment options included lifestyle changes, metformin, and oral contraceptive pills (OCP), with metformin showing minor weight loss benefits and OCP improving sex-hormone levels but causing slight weight gain. The study emphasized the importance of combined treatment with metformin and OCP, even for normal-weight patients, and called for more data to optimize patient evaluation and treatment strategies.